Shivani Ampoules & Vials Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.30 M
as on 16-11-2024
- Company Age 18 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit -26.71%
(FY 2023)
- Ebitda -26.71%
(FY 2023)
- Net Worth -65.45%
(FY 2023)
- Total Assets %
(FY 2023)
About Shivani Ampoules & Vials
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Satinder Bakshi and Seema Bakshi serve as directors at the Company.
- CIN/LLPIN
U24232DL2006PTC376008
- Company No.
162456
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shivani Ampoules & Vials?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satinder Bakshi  | Director | 08-May-2012 | Current |
| Seema Bakshi | Additional Director | 16-Oct-2020 | Current |
Financial Performance of Shivani Ampoules & Vials.
Shivani Ampoules & Vials Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 26.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 65.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shivani Ampoules & Vials?
In 2023, Shivani Ampoules & Vials had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bakson Homoeopathy Private Limited.Active 18 years 8 monthsSatinder Bakshi and Seema Bakshi are mutual person
Bakson Drugs And Pharmaceuticals Private LimitedActive 35 years 7 monthsSatinder Bakshi is a mutual person
Federation Of Homeopathic Manufacturers Of IndiaActive 22 years 1 monthSatinder Bakshi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shivani Ampoules & Vials?
Unlock and access historical data on people associated with Shivani Ampoules & Vials, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shivani Ampoules & Vials, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shivani Ampoules & Vials's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
